Netscientific PLC
LSE:NSCI
Intrinsic Value
NetScientific Plc is a healthcare medical technology company, which engages in sourcing, funding, and commercializing technologies that improve the health and well-being of people with chronic disease... [ Read More ]
The intrinsic value of one NSCI stock under the Base Case scenario is 50.42 GBX. Compared to the current market price of 67 GBX, Netscientific PLC is Overvalued by 25%.
Valuation Backtest
Netscientific PLC
Run backtest to discover the historical profit from buying and selling NSCI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Netscientific PLC
Current Assets | 1.6m |
Cash & Short-Term Investments | 852k |
Receivables | 550k |
Other Current Assets | 184k |
Non-Current Assets | 27.4m |
Long-Term Investments | 23.4m |
PP&E | 564k |
Intangibles | 3.4m |
Current Liabilities | 2.7m |
Accounts Payable | 497k |
Accrued Liabilities | 1.1m |
Other Current Liabilities | 1.2m |
Non-Current Liabilities | 389k |
Long-Term Debt | 987k |
Other Non-Current Liabilities | -598k |
Earnings Waterfall
Netscientific PLC
Revenue
|
1.4m
GBP
|
Cost of Revenue
|
-245k
GBP
|
Gross Profit
|
1.1m
GBP
|
Operating Expenses
|
-4.8m
GBP
|
Operating Income
|
-3.6m
GBP
|
Other Expenses
|
582k
GBP
|
Net Income
|
-3.1m
GBP
|
Free Cash Flow Analysis
Netscientific PLC
What is Free Cash Flow?
NSCI Profitability Score
Profitability Due Diligence
Netscientific PLC's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Netscientific PLC's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
NSCI Solvency Score
Solvency Due Diligence
Netscientific PLC's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Netscientific PLC's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSCI Price Targets Summary
Netscientific PLC
According to Wall Street analysts, the average 1-year price target for NSCI is 191.76 GBX with a low forecast of 189.88 GBX and a high forecast of 197.4 GBX.
Shareholder Return
NSCI Price
Netscientific PLC
Average Annual Return | 9.85% |
Standard Deviation of Annual Returns | 69.57% |
Max Drawdown | -89% |
Market Capitalization | 15.7m GBX |
Shares Outstanding | 23 945 800 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
NetScientific Plc is a healthcare medical technology company, which engages in sourcing, funding, and commercializing technologies that improve the health and well-being of people with chronic diseases. Its portfolio consists of a combination of direct investments and capital under advisory. The company has developed a customized investment and realization strategy for its portfolio companies through management, incubation, advisory services and fund-raising support. The company facilitates the companies it works with, to access the type of funding, management support and resources specific to their sector, stage of development and available opportunities. The firm's subsidiaries include EMV Capital Limited, Glycotest, Inc. and ProAxsis Limited, among others.
Officers
The intrinsic value of one NSCI stock under the Base Case scenario is 50.42 GBX.
Compared to the current market price of 67 GBX, Netscientific PLC is Overvalued by 25%.